SH Khoo

1.1k total citations
40 papers, 843 citations indexed

About

SH Khoo is a scholar working on Infectious Diseases, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, SH Khoo has authored 40 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 15 papers in Epidemiology and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in SH Khoo's work include HIV/AIDS drug development and treatment (27 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers) and HIV/AIDS Research and Interventions (11 papers). SH Khoo is often cited by papers focused on HIV/AIDS drug development and treatment (27 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers) and HIV/AIDS Research and Interventions (11 papers). SH Khoo collaborates with scholars based in United Kingdom, Uganda and Ireland. SH Khoo's co-authors include David Back, David W. Denning, Jennifer Lynn Ford, Andrew Owen, Umesh Lalloo, Christopher Jack, Gerald Friedland, DJ Back, D.J. Back and Kay Seden and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, British Journal of Pharmacology and Thorax.

In The Last Decade

SH Khoo

39 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SH Khoo United Kingdom 15 614 275 200 166 123 40 843
Concepta Merry Ireland 18 780 1.3× 411 1.5× 216 1.1× 187 1.1× 126 1.0× 29 1.1k
Kristel M. L. Crommentuyn Netherlands 16 661 1.1× 334 1.2× 154 0.8× 246 1.5× 105 0.9× 21 864
Deirdre Egan United Kingdom 15 730 1.2× 356 1.3× 199 1.0× 223 1.3× 137 1.1× 26 955
Agnes I. Veldkamp Netherlands 17 697 1.1× 510 1.9× 185 0.9× 140 0.8× 118 1.0× 27 943
Katy H. P. Moore United States 16 745 1.2× 393 1.4× 305 1.5× 120 0.7× 123 1.0× 24 1.1k
Charles la Porte Canada 13 478 0.8× 339 1.2× 199 1.0× 99 0.6× 97 0.8× 30 970
Rosa F. Yeh United States 12 348 0.6× 166 0.6× 135 0.7× 105 0.6× 62 0.5× 25 682
Natsuo Tachikawa Japan 16 533 0.9× 217 0.8× 284 1.4× 66 0.4× 92 0.7× 74 999
Caroline Solas France 23 920 1.5× 430 1.6× 258 1.3× 162 1.0× 171 1.4× 94 1.5k
P. L. Meenhorst Netherlands 19 682 1.1× 355 1.3× 261 1.3× 134 0.8× 115 0.9× 37 1.1k

Countries citing papers authored by SH Khoo

Since Specialization
Citations

This map shows the geographic impact of SH Khoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SH Khoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SH Khoo more than expected).

Fields of papers citing papers by SH Khoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SH Khoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SH Khoo. The network helps show where SH Khoo may publish in the future.

Co-authorship network of co-authors of SH Khoo

This figure shows the co-authorship network connecting the top 25 collaborators of SH Khoo. A scholar is included among the top collaborators of SH Khoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SH Khoo. SH Khoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khoo, SH, et al.. (2024). Ocular Surface Disease and Dry Eye Severity in Glaucoma Patients at Urban Private Eye Care Centres in Malaysia. Clinical ophthalmology. Volume 18. 3249–3262.
2.
Carr, Daniel F., Andrea Jorgensen, SH Khoo, et al.. (2014). CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations. Journal of Antimicrobial Chemotherapy. 69(12). 3329–3334. 26 indexed citations
3.
Byakika‐Kibwika, Pauline, Mohammed Lamorde, Jonathan Mayito, et al.. (2012). Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults. Journal of Antimicrobial Chemotherapy. 67(9). 2213–2221. 70 indexed citations
4.
Seden, Kay, Happy Mathew Tirivangasi, Matthew J. Bradley, et al.. (2012). Patients accessing HIV treatment via sexual health services: what are the risks of the dual case-note system?. International Journal of STD & AIDS. 23(2). 99–104. 3 indexed citations
5.
Schipani, Alessandro, Christoph Wyen, Tabitha Mahungu, et al.. (2011). Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals. Journal of Antimicrobial Chemotherapy. 66(6). 1332–1339. 40 indexed citations
6.
Lamorde, Mohammed, Pauline Byakika‐Kibwika, Máirín Ryan, et al.. (2010). Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin. Journal of Antimicrobial Chemotherapy. 66(1). 180–183. 14 indexed citations
7.
Lambert, John S., Valerie Jackson, Sara Gibbons, et al.. (2010). Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy. HIV Medicine. 12(3). 166–173. 31 indexed citations
8.
Dickinson, Laura, Akil Jackson, Victoria Watson, et al.. (2010). Population pharmacokinetic modelling of once‐daily ritonavir‐boosted darunavir in HIV‐infected patients. Journal of the International AIDS Society. 13(S4). 7 indexed citations
9.
Jackson, Valerie, et al.. (2010). Therapeutic drug monitoring (TDM) of atazanavir in pregnancy. Journal of the International AIDS Society. 13(S4). 3 indexed citations
10.
Seden, Kay, D.J. Back, & SH Khoo. (2009). Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable. Journal of Antimicrobial Chemotherapy. 64(1). 5–8. 27 indexed citations
11.
Janneh, Omar, Becky Chandler, Ruben C. Hartkoorn, et al.. (2009). Intracellular accumulation of efavirenz and nevirapine is independent of P-glycoprotein activity in cultured CD4 T cells and primary human lymphocytes. Journal of Antimicrobial Chemotherapy. 64(5). 1002–1007. 41 indexed citations
12.
Nair, D.R., Colette Smith, Deirdre Egan, et al.. (2009). The Relationships of ABCB1 3435C>T and CYP2B6 516G>T With High-Density Lipoprotein Cholesterol in HIV-Infected Patients Receiving Efavirenz. Clinical Pharmacology & Therapeutics. 86(2). 204–211. 8 indexed citations
13.
Liptrott, Neill J., Melissa A. Penny, Jean G. Sathish, et al.. (2009). The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. British Journal of Pharmacology. 156(3). 497–508. 63 indexed citations
14.
Wakeham, Katie, et al.. (2009). Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans. Journal of Antimicrobial Chemotherapy. 65(2). 316–319. 20 indexed citations
15.
Friedland, Gerald, SH Khoo, Christopher Jack, & Umesh Lalloo. (2006). Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV. Journal of Antimicrobial Chemotherapy. 58(6). 1299–1302. 87 indexed citations
16.
Ford, Jennifer Lynn, SH Khoo, & David Back. (2004). The intracellular pharmacology of antiretroviral protease inhibitors. Journal of Antimicrobial Chemotherapy. 54(6). 982–990. 86 indexed citations
17.
Hoggard, Patrick G., et al.. (2001). Zidovudine Phosphorylation and Mitochondrial Toxicity in Vitro. Toxicology and Applied Pharmacology. 177(1). 54–58. 31 indexed citations
18.
Jones, Kevin F., et al.. (2001). Effect of α1‐acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro. British Journal of Clinical Pharmacology. 51(1). 99–102. 28 indexed citations
19.
Back, DJ, et al.. (2000). Current uses and future hopes for clinical pharmacology in the management of HIV infection. HIV Medicine. 1(s2). 12–17. 3 indexed citations
20.
Khoo, SH, et al.. (1994). Administering amphotericin B—a practical approach. Journal of Antimicrobial Chemotherapy. 33(2). 203–213. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Concepta Merry Breakdown of academic impact, for papers by Kristel M. L. Crommentuyn Breakdown of academic impact, for papers by Deirdre Egan Breakdown of academic impact, for papers by Agnes I. Veldkamp Breakdown of academic impact, for papers by Katy H. P. Moore Breakdown of academic impact, for papers by Charles la Porte Breakdown of academic impact, for papers by Rosa F. Yeh Breakdown of academic impact, for papers by Natsuo Tachikawa Breakdown of academic impact, for papers by Caroline Solas Breakdown of academic impact, for papers by P. L. Meenhorst
Rankless by CCL
2026